Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. Int J Gynecol Cancer. 2022 07 04; 32(7):869-874.

View in: PubMed

subject areas

beta Catenin
Carcinoma, Endometrioid
Endometrial Neoplasms
Female
Humans
Mutation
Neoplasm Recurrence, Local
Neoplasm Staging
Radiotherapy, Adjuvant
Retrospective Studies

authors with profiles

Katherine Kurnit